Famotidine | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Famotidine
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Famotidine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

62 API Suppliers, 24 USDMF, 16 CEP/COS, 13 JDMF, 16 EU WC, 34 KDMF, 26 NDC API, 36 Listed Suppliers, $ API Reference Price

62 API Suppliers
24 USDMF
16 CEP/COS
13 JDMF
16 EU WC
34 KDMF
26 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

222 FDF Dossiers, 144 FDA Orange Book, 24 Europe, 17 Canada, 2 Australia, 35 Listed Dossiers

222 FDF Dossiers
144 FDA Orange Book
24 Europe
17 Canada
2 Australia
35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Evonik, 7 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 6 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 30 BASF, 1 Bioplus Life Sciences, 2 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 28 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 71 Coating Systems & Additives, 39 Controlled & Modified Release, 35 Solubilizers, 35 Thickeners and Stabilizers, 34 Disintegrants & Superdisintegrants, 34 Direct Compression, 29 Taste Masking, 28 Granulation, 25 Parenteral, 22 Topical, 18 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 10 Emulsifying Agents, 10 Rheology Modifiers, 8 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents

92 Fillers, Diluents & Binders
71 Coating Systems & Additives
39 Controlled & Modified Release
35 Solubilizers
35 Thickeners and Stabilizers
34 Disintegrants & Superdisintegrants
34 Direct Compression
29 Taste Masking
28 Granulation
25 Parenteral
22 Topical
18 Chewable & Orodispersible Aids
17 Lubricants & Glidants
16 Film Formers & Plasticizers
16 Co-Processed Excipients
10 Emulsifying Agents
10 Rheology Modifiers
8 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
4 Vegetarian Capsules
4 Coloring Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 61 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
61 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 31 Finished Drug Prices, 3 Annual Reports

4 US Medicaid Prescriptions
31 Finished Drug Prices
3 Annual Reports

MARKET PLACE

42 APIs, 42 FDF Dossiers

42 APIs
42 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 4 Health Canada Patents

5 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 6 USP, 16 Others

3 EDQM
6 USP
16 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 83 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5HORIZON

filter Patent Number Reset all filters

5 All

01 18067451

02 18309127

03 18318202

04 18449910

05 18501228

filter API Patent Reset all filters

5 All

01 5Blank

filter FDF Patent Reset all filters

5 All

01 4Y

02 1Blank

filter Expiration Date Reset all filters

5 All

01 52026-07-18

Product Main Page

01

HORIZON

FAMOTIDINE; IBUPROFEN

The Generic Rx Session

Not Confirmed

HORIZON

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-18

FAMOTIDINE; IBUPROFEN

US Patent Number : 8067451

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code : U-1196

Delist Requested :

Patent Use Description : RELIEF OF SIGNS AND SY...

Patent Expiration Date : 2026-07-18

Portfolio PDF

Product Web Link

Digital Content

02

HORIZON

FAMOTIDINE; IBUPROFEN

The Generic Rx Session

Not Confirmed

HORIZON

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-18

FAMOTIDINE; IBUPROFEN

US Patent Number : 8501228

Drug Substance Claim :

Drug Product Claim :

Application Number : 22519

Patent Use Code : U-1196

Delist Requested :

Patent Use Description : RELIEF OF SIGNS AND SY...

Patent Expiration Date : 2026-07-18

Portfolio PDF

Product Web Link

Digital Content

03

HORIZON

FAMOTIDINE; IBUPROFEN

The Generic Rx Session

Not Confirmed

HORIZON

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-18

FAMOTIDINE; IBUPROFEN

US Patent Number : 8318202

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-18

Portfolio PDF

Product Web Link

Digital Content

04

HORIZON

FAMOTIDINE; IBUPROFEN

The Generic Rx Session

Not Confirmed

HORIZON

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-18

FAMOTIDINE; IBUPROFEN

US Patent Number : 8309127

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-18

Portfolio PDF

Product Web Link

Digital Content

05

HORIZON

FAMOTIDINE; IBUPROFEN

The Generic Rx Session

Not Confirmed

HORIZON

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-18

FAMOTIDINE; IBUPROFEN

US Patent Number : 8449910

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-18

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!